JCB logo
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 24 May 2004. doi:10.1083/jcb.20040511165357
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 165, Number 4, 593-593
This Article
Right arrow Full Text (PDF, 28K)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Subramaniam, S.
Right arrow Articles by Unsicker, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Subramaniam, S.
Right arrow Articles by Unsicker, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Correction



Srinivasa Subramaniam, Ute Zirrgiebel, Oliver von Bohlen und Halbach, Jens Strelau, Christine Laliberté, David R. Kaplan, and Klaus Unsicker

Vol. 165, No. 3, May 10, 2004. Pages 357–369.

This article originally appeared with errors in the legend to Fig. 7. The cyclohexamide (CHX) concentration should be 10 µg/ml, not 10 g/ml as published. The correct text is printed below.

Figure 7. Effect of antioxidants and protein synthesis inhibitor on neuronal degeneration and ERK/caspase-3 activation. At the time of potassium change (low K+), 5 mM N-acetyl cystein (N-AC), 50 U/ml superoxide dismutase (SOD), or 10 µg/ml cyclohexamide (CHX) was added; and triple staining and Western blot analysis were performed at the indicated time points. (A) The triple staining for the aforementioned groups at 24 h. ***P < 0.001, **P < 0.01, and *P < 0.05 compared with untreated cultures. (B) Western blot probed for total ERK (ERK), p-ERK, and caspase-3. (C) 5 mM N-AC, 50 U/ml SOD, and 10 µg/ml CHX were added immediately after potassium change, and cell extracts were assayed for caspase-3 activation; —, untreated; blank, without cell extract. Error bars represent mean ± SEM from at least six experiments. (D) CHX does not act by binding to ERK and caspase-3. 10 µg/ml CHX was added at 0 and 12 h after the potassium switch. 20 µM U0126 was added at 12 h. The cell lysates were isolated after 13 h and processed for caspase-3 and ERK activation. Tubulin and total ERK blots reveal total protein loading.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF, 28K)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Subramaniam, S.
Right arrow Articles by Unsicker, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Subramaniam, S.
Right arrow Articles by Unsicker, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents